Diabetes in Europe

An update

T Tamayo, J Rosenbauer, S H Wild, A M W Spijkerman, C.A. Baan, N G Forouhi, C Herder, W Rathmann

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Diabetes is among the leading causes of death in the IDF Europe Region (EUR), continues to increase in prevalence with diabetic macro- and microvascular complications resulting in increased disability and enormous healthcare costs. In 2013, the number of people with diabetes is estimated to be 56 million in EUR with an overall estimated prevalence of 8.5%. However, estimates of diabetes prevalence in 2013 vary widely in the 56 diverse countries in EUR from 2.4% in Moldova to 14.9% in Turkey. Trends in diabetes prevalence also vary between countries with stable prevalence since 2002 for many countries but a doubling of diabetes prevalence in Turkey. For 2035, a further increase of nearly 10 million people with diabetes is projected for the EUR. Prevalence of type 1 has also increased over the past 20 years in EUR and there was estimated to be 129,350 cases in children aged 0-14 years in 2013. Registries provide valid information on incidence of type 1 diabetes with more complete data available for children than for adults. There are large differences in distribution of risk factors for diabetes at the population level in EUR. Modifiable risk factors such as obesity, physical inactivity, smoking behaviour (including secondhand smoking), environmental pollutants, psychosocial factors and socioeconomic deprivation could be tackled to reduce the incidence of type 2 diabetes in Europe. In addition, diabetes management is a major challenge to health services in the European countries. Improved networking practices of health professionals and other stakeholders in combination with empowerment of people with diabetes and continuous quality monitoring need to be further developed in Europe.

Original languageEnglish
Pages (from-to)206-17
Number of pages12
JournalDiabetes Research and Clinical Practice
Volume103
Issue number2
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Turkey
Moldova
Environmental Pollutants
Incidence
Type 2 Diabetes Mellitus
Health Services
Cause of Death

Keywords

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1/epidemiology
  • Diabetes Mellitus, Type 2/epidemiology
  • Europe/epidemiology
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Life Style
  • Male
  • Prevalence
  • Quality of Life
  • Registries
  • Risk Factors
  • Young Adult

Cite this

Tamayo, T., Rosenbauer, J., Wild, S. H., Spijkerman, A. M. W., Baan, C. A., Forouhi, N. G., ... Rathmann, W. (2014). Diabetes in Europe: An update. Diabetes Research and Clinical Practice, 103(2), 206-17. https://doi.org/10.1016/j.diabres.2013.11.007
Tamayo, T ; Rosenbauer, J ; Wild, S H ; Spijkerman, A M W ; Baan, C.A. ; Forouhi, N G ; Herder, C ; Rathmann, W. / Diabetes in Europe : An update. In: Diabetes Research and Clinical Practice. 2014 ; Vol. 103, No. 2. pp. 206-17.
@article{a58812134f984433842c9bd677fcccd2,
title = "Diabetes in Europe: An update",
abstract = "Diabetes is among the leading causes of death in the IDF Europe Region (EUR), continues to increase in prevalence with diabetic macro- and microvascular complications resulting in increased disability and enormous healthcare costs. In 2013, the number of people with diabetes is estimated to be 56 million in EUR with an overall estimated prevalence of 8.5{\%}. However, estimates of diabetes prevalence in 2013 vary widely in the 56 diverse countries in EUR from 2.4{\%} in Moldova to 14.9{\%} in Turkey. Trends in diabetes prevalence also vary between countries with stable prevalence since 2002 for many countries but a doubling of diabetes prevalence in Turkey. For 2035, a further increase of nearly 10 million people with diabetes is projected for the EUR. Prevalence of type 1 has also increased over the past 20 years in EUR and there was estimated to be 129,350 cases in children aged 0-14 years in 2013. Registries provide valid information on incidence of type 1 diabetes with more complete data available for children than for adults. There are large differences in distribution of risk factors for diabetes at the population level in EUR. Modifiable risk factors such as obesity, physical inactivity, smoking behaviour (including secondhand smoking), environmental pollutants, psychosocial factors and socioeconomic deprivation could be tackled to reduce the incidence of type 2 diabetes in Europe. In addition, diabetes management is a major challenge to health services in the European countries. Improved networking practices of health professionals and other stakeholders in combination with empowerment of people with diabetes and continuous quality monitoring need to be further developed in Europe.",
keywords = "Adolescent, Adult, Child, Child, Preschool, Diabetes Mellitus, Type 1/epidemiology, Diabetes Mellitus, Type 2/epidemiology, Europe/epidemiology, Female, Humans, Incidence, Infant, Infant, Newborn, Life Style, Male, Prevalence, Quality of Life, Registries, Risk Factors, Young Adult",
author = "T Tamayo and J Rosenbauer and Wild, {S H} and Spijkerman, {A M W} and C.A. Baan and Forouhi, {N G} and C Herder and W Rathmann",
note = "Copyright {\circledC} 2013 Elsevier Ireland Ltd. All rights reserved.",
year = "2014",
month = "2",
doi = "10.1016/j.diabres.2013.11.007",
language = "English",
volume = "103",
pages = "206--17",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Tamayo, T, Rosenbauer, J, Wild, SH, Spijkerman, AMW, Baan, CA, Forouhi, NG, Herder, C & Rathmann, W 2014, 'Diabetes in Europe: An update', Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 206-17. https://doi.org/10.1016/j.diabres.2013.11.007

Diabetes in Europe : An update. / Tamayo, T; Rosenbauer, J; Wild, S H; Spijkerman, A M W; Baan, C.A.; Forouhi, N G; Herder, C; Rathmann, W.

In: Diabetes Research and Clinical Practice, Vol. 103, No. 2, 02.2014, p. 206-17.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Diabetes in Europe

T2 - An update

AU - Tamayo, T

AU - Rosenbauer, J

AU - Wild, S H

AU - Spijkerman, A M W

AU - Baan, C.A.

AU - Forouhi, N G

AU - Herder, C

AU - Rathmann, W

N1 - Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

PY - 2014/2

Y1 - 2014/2

N2 - Diabetes is among the leading causes of death in the IDF Europe Region (EUR), continues to increase in prevalence with diabetic macro- and microvascular complications resulting in increased disability and enormous healthcare costs. In 2013, the number of people with diabetes is estimated to be 56 million in EUR with an overall estimated prevalence of 8.5%. However, estimates of diabetes prevalence in 2013 vary widely in the 56 diverse countries in EUR from 2.4% in Moldova to 14.9% in Turkey. Trends in diabetes prevalence also vary between countries with stable prevalence since 2002 for many countries but a doubling of diabetes prevalence in Turkey. For 2035, a further increase of nearly 10 million people with diabetes is projected for the EUR. Prevalence of type 1 has also increased over the past 20 years in EUR and there was estimated to be 129,350 cases in children aged 0-14 years in 2013. Registries provide valid information on incidence of type 1 diabetes with more complete data available for children than for adults. There are large differences in distribution of risk factors for diabetes at the population level in EUR. Modifiable risk factors such as obesity, physical inactivity, smoking behaviour (including secondhand smoking), environmental pollutants, psychosocial factors and socioeconomic deprivation could be tackled to reduce the incidence of type 2 diabetes in Europe. In addition, diabetes management is a major challenge to health services in the European countries. Improved networking practices of health professionals and other stakeholders in combination with empowerment of people with diabetes and continuous quality monitoring need to be further developed in Europe.

AB - Diabetes is among the leading causes of death in the IDF Europe Region (EUR), continues to increase in prevalence with diabetic macro- and microvascular complications resulting in increased disability and enormous healthcare costs. In 2013, the number of people with diabetes is estimated to be 56 million in EUR with an overall estimated prevalence of 8.5%. However, estimates of diabetes prevalence in 2013 vary widely in the 56 diverse countries in EUR from 2.4% in Moldova to 14.9% in Turkey. Trends in diabetes prevalence also vary between countries with stable prevalence since 2002 for many countries but a doubling of diabetes prevalence in Turkey. For 2035, a further increase of nearly 10 million people with diabetes is projected for the EUR. Prevalence of type 1 has also increased over the past 20 years in EUR and there was estimated to be 129,350 cases in children aged 0-14 years in 2013. Registries provide valid information on incidence of type 1 diabetes with more complete data available for children than for adults. There are large differences in distribution of risk factors for diabetes at the population level in EUR. Modifiable risk factors such as obesity, physical inactivity, smoking behaviour (including secondhand smoking), environmental pollutants, psychosocial factors and socioeconomic deprivation could be tackled to reduce the incidence of type 2 diabetes in Europe. In addition, diabetes management is a major challenge to health services in the European countries. Improved networking practices of health professionals and other stakeholders in combination with empowerment of people with diabetes and continuous quality monitoring need to be further developed in Europe.

KW - Adolescent

KW - Adult

KW - Child

KW - Child, Preschool

KW - Diabetes Mellitus, Type 1/epidemiology

KW - Diabetes Mellitus, Type 2/epidemiology

KW - Europe/epidemiology

KW - Female

KW - Humans

KW - Incidence

KW - Infant

KW - Infant, Newborn

KW - Life Style

KW - Male

KW - Prevalence

KW - Quality of Life

KW - Registries

KW - Risk Factors

KW - Young Adult

U2 - 10.1016/j.diabres.2013.11.007

DO - 10.1016/j.diabres.2013.11.007

M3 - Article

VL - 103

SP - 206

EP - 217

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 2

ER -

Tamayo T, Rosenbauer J, Wild SH, Spijkerman AMW, Baan CA, Forouhi NG et al. Diabetes in Europe: An update. Diabetes Research and Clinical Practice. 2014 Feb;103(2):206-17. https://doi.org/10.1016/j.diabres.2013.11.007